498 related articles for article (PubMed ID: 21576434)
21.
Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China.
Hu H; Shi Q; Zhang P; Quan J; Han X; Zhao D; Zhang H; Wang Q; Jiang Y; Yu Y
Int J Antimicrob Agents; 2023 Aug; 62(2):106873. PubMed ID: 37276893
[TBL] [Abstract][Full Text] [Related]
23. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
[TBL] [Abstract][Full Text] [Related]
24. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
[TBL] [Abstract][Full Text] [Related]
26. Analyzing pmrA and pmrB genes in Acinetobacter baumannii resistant to colistin in Shahid Rajai Shiraz, Iran Hospital by PCR: First report in Iran.
Sepahvand S; Doudi M; Davarpanah MA; Bahador A; Ahmadi M
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1401-6. PubMed ID: 27592491
[TBL] [Abstract][Full Text] [Related]
27. Promoters of Colistin Resistance in
Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
[No Abstract] [Full Text] [Related]
28. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant
Vijayakumar S; Swetha RG; Bakthavatchalam YD; Vasudevan K; Abirami Shankar B; Kirubananthan A; Walia K; Ramaiah S; Biswas I; Veeraraghavan B; Anbarasu A
Microbiol Spectr; 2024 Feb; 12(2):e0251123. PubMed ID: 38214512
[TBL] [Abstract][Full Text] [Related]
29. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.
Martínez-Guitián M; Vázquez-Ucha JC; Odingo J; Parish T; Poza M; Waite RD; Bou G; Wareham DW; Beceiro A
Antimicrob Agents Chemother; 2016 Jul; 60(7):4375-9. PubMed ID: 27139471
[TBL] [Abstract][Full Text] [Related]
30. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
[TBL] [Abstract][Full Text] [Related]
31. ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin.
Potron A; Vuillemenot JB; Puja H; Triponney P; Bour M; Valot B; Amara M; Cavalié L; Bernard C; Parmeland L; Reibel F; Larrouy-Maumus G; Dortet L; Bonnin RA; Plésiat P
J Antimicrob Chemother; 2019 Sep; 74(9):2544-2550. PubMed ID: 31199431
[TBL] [Abstract][Full Text] [Related]
32.
Ko SY; Kim N; Park SY; Kim SY; Shin M; Lee JC
Antibiotics (Basel); 2023 Apr; 12(5):. PubMed ID: 37237716
[TBL] [Abstract][Full Text] [Related]
33. An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.
Oddo A; Thomsen TT; Kjelstrup S; Gorey C; Franzyk H; Frimodt-Møller N; Løbner-Olesen A; Hansen PR
Antimicrob Agents Chemother; 2016 Jan; 60(1):592-9. PubMed ID: 26574005
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe.
Goic-Barisic I; Music MS; Drcelic M; Tuncbilek S; Akca G; Jakovac S; Tonkić M; Hrenovic J
J Glob Antimicrob Resist; 2023 Jun; 33():26-30. PubMed ID: 36878462
[TBL] [Abstract][Full Text] [Related]
35. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
Leite GC; Stabler RA; Neves P; Perdigão Neto LV; Ruedas Martins RC; Rizek C; Rossi F; Levin AS; Costa SF
Diagn Microbiol Infect Dis; 2019 Sep; 95(1):99-101. PubMed ID: 31178071
[TBL] [Abstract][Full Text] [Related]
36. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.
Jayol A; Poirel L; Brink A; Villegas MV; Yilmaz M; Nordmann P
Antimicrob Agents Chemother; 2014 Aug; 58(8):4762-6. PubMed ID: 24914122
[TBL] [Abstract][Full Text] [Related]
37. Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy.
Srisakul S; Wannigama DL; Higgins PG; Hurst C; Abe S; Hongsing P; Saethang T; Luk-In S; Liao T; Kueakulpattana N; Shein AMS; Gan L; Kupwiwat R; Tanasatitchai C; Wapeesittipan P; Phattharapornjaroen P; Badavath VN; Leelahavanichkul A; Chatsuwan T
Sci Rep; 2022 Jul; 12(1):11390. PubMed ID: 35794134
[TBL] [Abstract][Full Text] [Related]
38. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
Jaidane N; Naas T; Mansour W; Radhia BB; Jerbi S; Boujaafar N; Bouallegue O; Bonnin RA
Int J Antimicrob Agents; 2018 Feb; 51(2):266-269. PubMed ID: 29127051
[TBL] [Abstract][Full Text] [Related]
39. Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure.
Marano V; Marascio N; Pavia G; Lamberti AG; Quirino A; Musarella R; Casalinuovo F; Mazzitelli M; Trecarichi EM; Torti C; Matera G; Liberto MC
Microb Pathog; 2020 Feb; 142():104058. PubMed ID: 32058026
[TBL] [Abstract][Full Text] [Related]
40. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
